The Research and Development team at Biosplice Therapeutics focuses on advancing the company's core platform of small molecule-based Wnt pathway modulation. They innovate and develop new therapeutics for addressing degenerative diseases, regenerative medicine, and oncology. The team's responsibilities include biological research, compound management, medicinal chemistry, and discovering novel therapeutic targets to improve patient outcomes.
View all